logo
episode-header-image
Jul 2023
9m 3s

Treatments for Alzheimer’s, finally

Financial Times
About this episode

The Nasdaq Composite had its biggest one-day drop in more than four months, the winner of Thailand’s general election has been suspended from parliament, and the FT’s Clive Cookson tells us about two huge breakthroughs in the treatment of Alzheimer’s. 


Mentioned in this podcast:

Nasdaq drops more than 2% after Netflix and Tesla results disappoint

Thai election winner blocked from premiership

Eli Lilly drug shown to slow Alzheimer’s progression


The FT News Briefing is produced by Fiona Symon, Sonja Hutson and Marc Filippino. Additional help from Saffeya Ahmed, Monica Lopez, Katie McMurran, Peter Barber, Michael Lello, David da Silva and Gavin Kallmann. Topher Forhecz is the FT’s executive producer. The FT’s global head of audio is Cheryl Brumley. The show’s theme song is by Metaphor Music. 


Read a transcript of this episode on FT.com


Hosted on Acast. See acast.com/privacy for more information.

Up next
Yesterday
Martin Wolf on the US midterms: What’s the risk of political violence?
As Americans prepare to vote in the November 3 midterm elections, the FT’s chief economics commentator Martin Wolf asks what the result will mean for Donald Trump, the future of US democracy and America's place in the world. In the third of a six-part series, Martin speaks to pol ... Show More
36m 54s
Oct 30
Alphabet’s brutal day on the stock market
Alphabet’s share price fell just over 12 percent on Thursday, and UK startup Nscale is banking on a troubled US data centre project to underpin its planned $35bn IPO. Plus, we look at what’s next for the ECB now that its president Christine Lagarde announced she’s stepping down.M ... Show More
12m 15s
Oct 29
The winners and losers in the UK Budget
Chancellor John Healey has targeted banks, savers and property owners in his Autumn Budget, Benjamin Netanyahu holds the lead in Israel’s election but there’s no clear winner yet, and one of the oldest American law firms told partners that it should dissolve. Plus, the Federal Re ... Show More
13m 28s
Recommended Episodes
Nov 2022
David Cameron on the Alzheimer's Breakthrough
The former prime minister says it’s his “happiest day” as president of Alzheimer’s Research UK, after the discovery of the first drug to slow the disease.He also speaks about whether he did enough during his premiership to support those who needed dementia care.And, the BBC’s hea ... Show More
26m 52s
Apr 2023
Audio long read: Conquering Alzheimer’s — a look at the therapies of the future
Last year, researchers announced that the Alzheimer’s drug lecanemab lowered the amount of amyloid protein plaques associated with the disease in the brains of participants in a clinical trial, and slowed their cognitive decline.Now, researchers are looking to drug combinations, ... Show More
17m 31s
Apr 2022
Dementia: Could lessons from Covid help find a cure?
Just before the pandemic, the government promised a 'dementia moonshot' to blast us towards a dementia cure. What happened to it?Today: former prime minister David Cameron and Sunday Times science editor Ben Spencer on Britain’s fastest growing disease, dementia.This podcast was ... Show More
30m 42s
Jun 2023
Biden Wins the Debt Deal, and AI Extinction
Elizabeth Holmes goes to prison, the Sackler family escapes liability, and Twitter's valuation drops even lower. Also, Congress votes to raise the debt ceiling, but did Speaker McCarthy get floored? Leading AI scientists and entrepreneurs warn of possible extinction. Kara and Sco ... Show More
1h 4m